Basic information Safety Supplier Related

CGP4540

Basic information Safety Supplier Related

CGP4540 Basic information

Product Name:
CGP4540
Synonyms:
  • (4-Isothiocyanato-phenyl)-(4-nitro-phenyl)-amine
  • CGP4540 (Amoscanate)
  • CGP-4540;CGP 4540;CGP4540;NITHIOCYAMINE
  • Benzen-t-amine, 4-isothiocyanato-N-(4-nitrophenyl)-
CAS:
100990-46-3
MW:
0
Mol File:
Mol File
More
Less

CGP4540 Usage And Synthesis

Definition

ChEBI: Amoscanate is an isothiocyanate that is phenyl isothiocyanate in which the hydrogen at the para- position has been replaced by a 4-nitroanilinyl group. It has a role as a schistosomicide drug. It is a C-nitro compound, an isothiocyanate and a secondary amino compound. It is functionally related to a diphenylamine.

Biological Activity

Amoscanate (cgp4540) is phenyl isothiocyanate in which the hydrogen at the para-position has been replaced by a 4-nitroanilinyl group. Amoscanate is an anti-schistosomal agent. Amoscanate, as an isothiocyanate compound and uncoupler of oxidative phosphorylation, potently injures rodent ependyma[1]. Amoscanate (500 mg/kg; p.o.; 10 days) destructs ependyma and periventricular brain[1].Amoscanate (250 and 500 mg/kg; p.o.; 28 days) elicits necrosis, Ca++-positive microgranules, pyknosis and edema localized in ependyma/subependyma in the medial striatum[1].Amoscanate (25~500 mg/kg; p.o.; 20 days) elicits progressive necrosis of ependyma[1].Amoscanate elicits massive ultrastructural damage in ependymal cells[1].

References

[1]. Johanson C, et al. The distributional nexus of choroid plexus to cerebrospinal fluid, ependyma and brain: toxicologic/pathologic phenomena, periventricular destabilization, and lesion spread. Toxicol Pathol. 2011;39(1):186-212.

CGP4540Supplier

Shanghai JiYi Biotechnology Co. Ltd.
Tel
13621943973
Email
sales@shjiyipharmatech.com
Shanghai Chaolan Chemical Technology Center
Tel
QQ:65489617 15618227136
Email
info@SuperLan-chem.com
Amadis Chemical Company Limited
Tel
571-89925085
Email
sales@amadischem.com
Medi-tech Bioscientific Co., Ltd.
Tel
0519-83246372 13585352506
Nanjing KaiMubo Pharmaceutical Co., Ltd.
Tel
025-66162170